Issue of Equity

10 February 2011

                              Sareum Holdings plc
                          ("Sareum" or "the Company")

                           Placing to raise £500,000

The  Company  announces  that,  following  investor demand, it has conditionally
raised  £500,000,  before  expenses,  by  way  of  a  placing by Hybridan LLP of
50,000,000 new ordinary shares of 0.025p each in the capital of the Company (the
"Placing  Shares") at 1p per share, representing  a 40 per cent. discount to the
closing  market price of  1.65 pence on 8 February  2011, the price which formed
the  basis for the Board's decision to undertake the placing. The Placing Shares
have been issued to Xcap Securities plc, on behalf of its clients.

Following the results of the recent study that was announced on 7 February 2011
Sareum  intends to use the proceeds of the placing to accelerate the advancement
of  the Aurora+FLT3  Kinase leukaemia  drug discovery  programme and for working
capital generally.

It  is  the  Board's  view  that  the  placing  is the most appropriate means of
providing  capital to  accelerate its  drug discovery  programmes and to provide
working  capital for the Company.  The cost of funds  raised through the placing
are  substantially  less  than  those  for  an  open  offer or a rights issue to
shareholders.

Application  will be made to the London Stock Exchange for the Placing Shares to
be  admitted to  trading on  AIM and  it is  expected that admission will become
effective and trading will commence on 15 February 2011. The Placing Shares will
rank pari passu with the existing ordinary shares of the Company.

Following  the admission of  the Placing Shares  to trading on  AIM, the Company
will have a total of 1,450,597,713 shares in issue.

Enquiries:

 Sareum Holdings plc

 Tim Mitchell                 01223 497 700



 Merchant Securities Limited (NOMAD)

 Simon Clements/Bidhi Bhoma   020 7628 2200



 Hybridan LLP (Broker)

 Claire Noyce                 020 7947 4350
















This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: SAREUM HOLDINGS PLC via Thomson Reuters ONE

[HUG#1487359]